ABMT for Social Anxiety Disorder
Trial Summary
What is the purpose of this trial?
This trial tests a computer-based therapy called ABMT on kids aged 10-14 with social anxiety. The therapy aims to help them focus less on negative social cues, which may reduce their anxiety. Researchers will compare brain activity and anxiety levels between those who get ABMT and those who do not. Attention Bias Modification Treatment (ABMT) is a novel computer-based treatment for anxiety disorders, proposed as an efficient and accessible psychological therapy.
Do I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you can continue a stable dose of stimulant or non-stimulant medication for ADHD.
What data supports the idea that ABMT for Social Anxiety Disorder is an effective treatment?
The available research shows that ABMT can be effective for treating social anxiety disorder. One study found that ABMT and another treatment, CBM-I, both helped reduce social anxiety. Another study showed that ABMT helped children who didn't respond to another treatment, CBT, by reducing their anxiety symptoms. This suggests that ABMT can be a useful option, especially for those who don't benefit from other treatments.12345
What safety data exists for Attention Bias Modification Treatment (ABMT) for Social Anxiety Disorder?
The provided research abstracts do not explicitly mention safety data for ABMT. They focus on the efficacy of ABMT in treating anxiety disorders, including social anxiety disorder, and its effects when combined with cognitive behavioral therapy (CBT). However, none of the studies specifically address safety outcomes or adverse effects related to ABMT.12456
Is Attention Bias Modification Treatment a promising treatment for Social Anxiety Disorder?
Yes, Attention Bias Modification Treatment (ABMT) is a promising treatment for Social Anxiety Disorder. Research shows that it helps reduce anxiety by changing how people focus on threats. It has been effective in both adults and young people, and it can also enhance other therapies like cognitive-behavioral group therapy.12578
Research Team
Wendy K Silverman, PhD
Principal Investigator
Yale University
Jeremy W Pettit, PhD
Principal Investigator
Florida International University
Eligibility Criteria
This trial is for youths aged 10-14 with Social Anxiety Disorder, without severe other psychiatric conditions or current psychotropic medication (except for stable ADHD treatment). They must not have a history of neurological illness, significant head injury, uncorrected vision or physical disabilities affecting mouse use, nor meet criteria for certain other disorders.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Attention Bias Modification Treatment (Behavioral Intervention)
- Neutral Control Task (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Florida International University
Lead Sponsor
Andrés G. Gil
Florida International University
Chief Executive Officer
PhD in Medical Sociology from the University of Miami
Dr. Stuart Hart
Florida International University
Chief Medical Officer
MD from Harvard Medical School
Yale University
Collaborator
Nancy J. Brown
Yale University
Chief Medical Officer since 2020
MD from Yale School of Medicine
Peter Salovey
Yale University
Chief Executive Officer since 2013
PhD in Psychology from Yale University